Identification Of High-risk Coronary Plaques By Multimodal Intravascular Imaging
Condition(s) studied
Investigational drug(s) / intervention(s)
Assessment of plaque morphology, structure, and stability in non-culprit lesions: Assessment of plaque morphology, structure, and stability in non-culprit lesions based on intravascular ultrasound and optical coherence tomography-near-infrared spectroscopy imaging technology.
Study summary
This study is a multicenter prospective observational clinical study, which will be conducted in 11 hospitals, and approximately 500 subjects will be enrolled. Plaque morphology and stability of non-culprit lesions were assessed by intravascular ultrasound (IVUS) and optical coherence tomography-near-infrared spectroscopy (OCT) after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). Plaques were grouped according to high-risk or non-high-risk. Clinical follow-up was conducted after PCI.
Eligibility
Primary outcome measure(s)
- Total MACE at 2 years — 1 month,1year,2 years
The total MACE (Major Adverse Cardiovascular Events) at 2 years post-surgery, including both culprit lesions and non-culprit lesions, is defined as a composite endpoint consisting of death, non-fatal myocardial infarction, and unplanned revascularization.
Trial sites (11)
| Facility | City | Region | Status |
|---|---|---|---|
| Shenzhen People's Hospital | Shenzhen | Guandong | |
| Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology | Wuhan | Hubei | |
| Wuhan Asian Heart Hospital | Wuhan | Hubei | |
| China-Japan Union Hospital of Jilin University | Changchun | Jilin | |
| Xi'an Jiaotong University Second Affiliated Hospital | Xi'an | Shaanxi | |
| People's Hospital of Xinjiang Uygur Autonomous Region | Ürümqi | Xinjiang Uygur Autonomous Region | |
| The Second Affiliated Hospital, Zhejiang University | Hangzhou | Zhejiang | |
| Beijing Anzhen Hospital, Capital Medical University | Beijing | China | |
| Beijing Jishuitan Hospital | Beijing | China | |
| Fuwai Hospital, Chinese Academy of Medical Sciences | Beijing | China | |
| People's Liberation Army General Hospital | Beijing | China |
More Chinese PLA General Hospital trials in Japan
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06681155 on ClinicalTrials.gov ↗ ← All trials in Japan